Date published: 2025-10-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

1110007A13Rik Inhibitors

Chemical inhibitors of 1110007A13Rik can disrupt its activity through various intracellular signaling pathways. LY294002 and Wortmannin are chemicals known to specifically target and inhibit phosphoinositide 3-kinases (PI3K). This inhibition is significant because PI3K is a critical enzyme involved in the initiation of several signaling pathways, which can include those regulating the activity of 1110007A13Rik. By blocking PI3K, LY294002 and Wortmannin can effectively suppress downstream signaling necessary for the functional activity of 1110007A13Rik. Similarly, Rapamycin exerts its inhibitory effects by selectively targeting and inhibiting the mammalian target of rapamycin (mTOR), which plays a key role in cell growth and proliferation. The inhibition of mTOR by Rapamycin can consequently lead to a reduction in the functions regulated by 1110007A13Rik.

Other chemicals act on different kinases within the signaling networks. PD98059 and U0126 are inhibitors of mitogen-activated protein kinase kinase (MEK), which is upstream of extracellular signal-regulated kinases (ERK). They can prevent the activation of ERK, potentially disrupting the signaling cascades that may regulate 1110007A13Rik. SB203580 and SP600125 focus on different MAP kinases; SB203580 targets p38 MAP kinase, while SP600125 inhibits c-Jun N-terminal kinase (JNK). Both of these inhibitors can obstruct their respective MAPK pathways, which are implicated in various cellular responses, including those involving 1110007A13Rik. Moreover, BAY 11-7082, by inhibiting NF-κB activation, can decrease signaling events crucial for 1110007A13Rik activity, and AG 490, as a tyrosine kinase inhibitor, can block the JAK/STAT pathway, reducing the signaling that is essential for the function of 1110007A13Rik. Dasatinib, a Src family kinase and BCR-ABL inhibitor, suppresses tyrosine kinase-mediated signaling that may involve 1110007A13Rik. Lastly, a broad-spectrum kinase inhibitor, Staurosporine, and an Aurora kinase inhibitor, ZM-447439, can affect various kinases including those which may regulate 1110007A13Rik, impacting cell cycle and mitosis.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3K), which are involved in various signaling pathways. Inhibition of PI3K can lead to the suppression of downstream signaling necessary for the activity of 1110007A13Rik.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin is another PI3K inhibitor that can block the PI3K/Akt pathway, thereby inhibiting the downstream effects that may be required for the proper functioning of 1110007A13Rik.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059 is an inhibitor of MEK, which is upstream of the ERK pathway. By inhibiting MEK, PD98059 can prevent the activation of ERK, which may be involved in the signaling cascades that regulate 1110007A13Rik's activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 is another MEK inhibitor that can block the MEK/ERK pathway, potentially leading to the inhibition of cellular processes that are dependent on this pathway, which may include those involving 1110007A13Rik.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is a p38 MAP kinase inhibitor, which can obstruct the p38 MAPK pathway. The inhibition of this pathway can disrupt processes that may contribute to the functional activity of 1110007A13Rik.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is an inhibitor of JNK, which can prevent the JNK signaling pathway's influence on cellular functions that involve 1110007A13Rik.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin selectively inhibits mTOR, a key regulator in cell growth and proliferation. The mTOR pathway's inhibition can lead to a reduction in the functions that are potentially regulated by 1110007A13Rik.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

BAY 11-7082 is known to inhibit NF-κB activation, which can decrease the signaling events that may be crucial for the activity of 1110007A13Rik.

AG-490

133550-30-8sc-202046C
sc-202046A
sc-202046B
sc-202046
5 mg
50 mg
25 mg
10 mg
$82.00
$323.00
$219.00
$85.00
35
(1)

AG 490 is a tyrosine kinase inhibitor that can block the JAK/STAT pathway. By inhibiting JAK, this chemical can reduce STAT activation and subsequent signaling, which may be essential for 1110007A13Rik's function.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Dasatinib is a Src family kinase and BCR-ABL inhibitor, which can suppress tyrosine kinase-mediated signaling. By inhibiting these kinases, dasatinib can prevent the activation of signaling pathways involving 1110007A13Rik.